Area of Focus: Personalized Medicine

Sometimes known as Precision Medicine, this medical model utilizes patient stratification to tailor treatments for more effective therapy. Stratification can be based on patient personal genetics, life-style, or characteristics of the disease tissue itself.

REPROCELL’s Centre for Predictive Drug Discovery (formerly Biopta) contract research services can employ precision-cut tissue sections, arraying primary tumor samples into multi-well plates for testing against a panel of drugs, drug combinations or various concentrations. Other assay configurations are also be possible, depending on the disease and target tissue.